Myrthe Rouwette

发表

Unraveling the Interaction between Carboxylesterase 1c and the Antibody–Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice

R. Ubink, Kim Berentsen, W. Dokter, 2018, Molecular Cancer Therapeutics.

The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers

R. Ubink, P. Beusker, W. Dokter, 2015, Molecular Cancer Therapeutics.

Progressive Sensorineural Hearing Loss and Normal Vestibular Function in a Dutch DFNB7/11 Family with a Novel Mutation in TMC1

C. Cremers, H. Kremer, R. Collin, 2010, Audiology and Neurotology.

Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis

M. Verbeek, P. Jongen, M. D'hooghe, 2014, The Journal of Immunology.

Response in Multiple Sclerosis Target of the Humoral Autoimmune Sperm-Associated Antigen 16 Is a Novel

Niels, M. Verbeek, P. Jongen, 2014 .

Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome

M. Verbeek, C. Sindic, J. Álvarez-cermeño, 2012, Journal of neurochemistry.

Identification of coronin‐1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis

M. Verbeek, P. Jongen, P. Stinissen, 2013, Journal of neurochemistry.

Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate

R. Ubink, Kim Berentsen, P. Groothuis, 2023, Molecular cancer therapeutics.